Treatment Outcomes of Pediatric Status Epilepticus in a Tertiary Pediatric Intensive Care Unit.


Journal

Pediatric emergency care
ISSN: 1535-1815
Titre abrégé: Pediatr Emerg Care
Pays: United States
ID NLM: 8507560

Informations de publication

Date de publication:
01 Jul 2021
Historique:
pubmed: 10 3 2020
medline: 19 8 2021
entrez: 10 3 2020
Statut: ppublish

Résumé

Status epilepticus is associated with high rates of morbidity and mortality; thus, early diagnosis and proper treatment are crucial. We aimed to study the etiology, clinical features, and treatment among pediatric patients with convulsive status epilepticus. The medical records of 100 patients were retrospectively obtained from pediatric intensive care unit. Etiology, clinical features, and treatment were interpreted by using Fisher exact test, χ2 test, and Spearman ρ correlation coefficient. Seizures had stopped with the first-, second-, and third-line treatment in 29%, 36%, and 35% of the patients, respectively. Only phenytoin treatment was efficient; it has 32.3% rate in second-line treatment. Whereas mortality rate was 10%, morbidity rate was 14% during the follow-up. Epilepsy, hemiparesis, spastic tetraparesis, and mental retardation developed. Mortality was significantly much more in the patients with refractory seizure and cerebral palsy. Development of mental retardation was much higher in the male sex. Phenytoin is still one of the most efficient antiepileptic drugs. If the duration of status epilepticus can be shortened by prompt treatment, neurological complications may be prevented.

Identifiants

pubmed: 32149989
pii: 00006565-202107000-00005
doi: 10.1097/PEC.0000000000001914
doi:

Substances chimiques

Anticonvulsants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

360-364

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure: The authors declare no conflict of interest.

Références

Santos MI, Nzwalo H, Monteiro JP, et al. Convulsive status epilepticus in the pediatric emergency department: five year retrospective analysis. Acta Med Port . 2012;25:203–206.
Chin RF, Neville BG, Peckham C, et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet . 2006;368:222–229.
Nishiyama I, Ohtsuka Y, Tsuda T, et al. An epidemiological study of children with status epilepticus in Okayama, Japan. Epilepsia . 2007;48:1133–1137.
Lambrechtsen FA, Buchhalter JR. Aborted and refractory status epilepticus in children: a comparative analysis. Epilepsia . 2008;49:615–625.
Abend NS, Loddenkemper T. Pediatric status epilepticus management. Curr Opin Pediatr . 2014;26:668–674.
ILAE. Guidelines for epidemiologic studies on epilepsy: Commission on Epidemiology and Prognosis, International League Against Epilepsy. Epilepsia . 1993;34:592–596.
Brophy GM, Bell R, Claassen J, et al; Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care . 2012;17:3–23.
Alldredge BK, Wall DB, Ferriero DM. Effect of prehospital treatment on the outcome of status epilepticus in children. Pediatr Neurol . 1995;12:213–216.
Silbergleit R, Lowenstein D, Durkalski V, et al. Lessons from the RAMPART study—and which is the best route of administration of benzodiazepines in status epilepticus. Epilepsia . 2013;54:74–77.
Abend NS, Gutierrez-Colina AM, Dlugos DJ. Medical treatment of pediatric status epilepticus. Semin Pediatr Neurol . 2010;17:169–175.
Appleton R, Macleod S, Martland T. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev . 2008;CD001905.
Wilkes R, Tasker RC. Pediatric intensive care treatment of uncontrolled status epilepticus. Crit Care Clin . 2013;29:239–257.
Neligan A, Shorvon S. Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review. Epilepsy Res . 2011;93:1–10.
Neville BG, Chin RF, Scott RC. Childhood convulsive status epilepticus: epidemiology, management and outcome. Acta Neurol Scand . 2007;186:21–24.
Valencia I, Lozano G, Kothare SV, et al. Epileptic seizures in the pediatric intensive care unit setting. Epileptic Disord . 2006;8:277–284.
Nishiyama I, Ohtsuka Y, Tsuda T, et al. An epidemiological study of children with status epilepticus in Okayama, Japan: incidence, etiologies, and outcomes. Epilepsy Res . 2011;96:89–95.
Lin KL, Lin JJ, Hsia SH, et al. Analysis of convulsive status epilepticus in children of Taiwan. Pediatr Neurol . 2009;41:413–418.
Tirupathi S, McMenamin JB, Webb DW. Analysis of factors influencing admission to intensive care following convulsive status epilepticus in children. Seizure . 2009;18:630–633.
Asadi-Pooya AA, Poordast A. Etiologies and outcomes of status epilepticus in children. Epilepsy Behav . 2005;7:502–505.
Coeytaux A, Jallon P, Galobardes B, et al. Incidence of status epilepticus in French-speaking Switzerland (EPISTAR). Neurology . 2000;55:693–697.
Komur M, Arslankoylu AE, Okuyaz C, et al. Management of patients with status epilepticus treated at a pediatric intensive care unit in Turkey. Pediatr Neurol . 2012;46:382–386.
Besli GE, Saltik S, Erguven M, et al. Status epilepticus in children: causes, clinical features and short-term outcome. Pediatr Int . 2010;52:749–753.
Saz EU, Karapinar B, Ozcetin M, et al. Convulsive status epilepticus in children: etiology, treatment protocol and outcome. Seizure . 2011;20:115–118.
Maytal J, Shinnar S, Moshé SL, et al. Low morbidity and mortality of status epilepticus in children. Pediatrics . 1989;83:323–331.
Mehta V, Singhi P, Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. J Child Neurol . 2007;22:1191–1197.
Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure . 2014;23:167–174.
Liu X, Wu Y, Chen Z, et al. A systematic review of randomized controlled trials on the theraputic effect of intravenous sodium valproate in status epilepticus. Int J Neurosci . 2012;122:277–283.
Kravljanac R, Jovic N, Djuric M, et al. Outcome of status epilepticus in children treated in the intensive care unit: a study of 302 cases. Epilepsia . 2011;52:358–563.
Minicucci F, Muscas G, Perucca E, et al. Treatment of status epilepticus in adults: guidelines of the Italian League Against Epilepsy. Epilepsia . 2006;47:9–15.
Halawa EF, Draz I, Ahmed D, et al. Predictors of outcome of convulsive status epilepticus among an Egyptian pediatric tertiary hospital. J Child Neurol . 2015;30:1736–1742.
Raspall-Chaure M, Chin RF, Neville BG, et al. The epidemiology of convulsive status epilepticus in children: a critical review. Epilepsia . 2007;48:1652–1663.
Himmelmann K, Sundh V. Survival with cerebral palsy over five decades in western Sweden. Dev Med Child Neurol . 2015;57:762–767.
Shah S, Shah N, Johnson R, et al. Single center outcomes of status epilepticus at a paediatric intensive care unit. Can J Neurol Sci . 2016;43:105–112.
Payne ET, Hahn CD. Continuous electroencephalography for seizures and status epilepticus. Curr Opin Pediatr . 2014;26:675–681.

Auteurs

Dilek Cavusoglu (D)

From the Department of Pediatric Neurology, Faculty of Medicine, Afyon Kocatepe University, Afyon.

Elif Esra Sınmaz (EE)

Department of Paediatrics, Liv Hospital, Istinye University, Istanbul.

Nihal Olgac Dundar (NO)

Department of Pediatric Neurology, Tepecik Training and Investigation Hospital, Faculty of Medicine, Izmir Katip Celebi University, Izmir.

Fulya Kamit Can (FK)

Department of Pediatric Intensive Care, Denizli Public Hospital, Denizli.

Ayse Berna Anil (AB)

Department of Pediatric Intensive Care, Faculty of Medicine, Izmir Katip Celebi University.

Berrak Sarioglu (B)

Department of Pediatric Neurology, Tepecik Training and Investigation Hospital, Izmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH